As of 2026-09-11, the EV/EBITDA ratio of Genoway SA (ALGEN.PA) is -8.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALGEN.PA's latest enterprise value is 38.47 mil EUR. ALGEN.PA's TTM EBITDA according to its financial statements is -4.67 mil EUR. Dividing these 2 quantities gives us the above ALGEN.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.7x - 15.2x | 11.7x |
| Forward P/E multiples | 6.1x - 6.6x | 6.1x |
| Fair Price | (4.08) - 2.76 | (1.17) |
| Upside | -263.1% - 10.4% | -146.7% |
| Date | EV/EBITDA |
| 2026-09-04 | -8.19 |
| 2026-09-03 | -8.25 |
| 2026-09-02 | -8.30 |
| 2026-09-01 | -8.14 |
| 2026-08-31 | -8.19 |
| 2026-08-28 | -8.16 |
| 2026-08-27 | -8.14 |
| 2026-08-26 | -8.11 |
| 2026-08-25 | -8.14 |
| 2026-08-24 | -8.08 |
| 2026-08-21 | -8.14 |
| 2026-08-20 | -8.11 |
| 2026-08-19 | -8.11 |
| 2026-08-18 | -8.11 |
| 2026-08-17 | -8.11 |
| 2026-08-14 | -8.19 |
| 2026-08-13 | -8.19 |
| 2026-08-12 | -8.30 |
| 2026-08-11 | -8.25 |
| 2026-08-10 | -8.25 |
| 2026-08-07 | -8.27 |
| 2026-08-06 | -8.25 |
| 2026-08-05 | -8.16 |
| 2026-08-04 | -8.19 |
| 2026-08-03 | -8.19 |
| 2026-07-31 | -8.08 |
| 2026-07-30 | -8.08 |
| 2026-07-29 | -8.19 |
| 2026-07-28 | -8.14 |
| 2026-07-27 | -8.25 |
| 2026-07-24 | -8.19 |
| 2026-07-23 | -8.16 |
| 2026-07-22 | -8.25 |
| 2026-07-21 | -8.25 |
| 2026-07-20 | -8.19 |
| 2026-07-17 | -8.44 |
| 2026-07-16 | -8.55 |
| 2026-07-15 | -7.92 |
| 2026-07-14 | -7.81 |
| 2026-07-13 | -7.92 |
| 2026-07-10 | -7.97 |
| 2026-07-09 | -7.65 |
| 2026-07-08 | -7.84 |
| 2026-07-07 | -8.06 |
| 2026-07-06 | -8.03 |
| 2026-07-03 | -8.00 |
| 2026-07-02 | -7.97 |
| 2026-07-01 | -7.97 |
| 2026-06-30 | -7.89 |
| 2026-06-29 | -7.86 |